Cycles of Transient High-Dose Cyclophosphamide Administration and Oncolytic Adenovirus Vector Intratumoral Injection for Long Term Tumor Suppression in Syrian Hamsters

Documenti analoghi

• Pre-existing Immunity and Passive Immunity to Adenovirus 5 Prevents Toxicity Caused by an Oncolytic Adenovirus Vector in the Syrian Hamster Model
  di: Dhar, Debanjan, et al.
  Pubblicazione: (2009)
• Effect of Preexisting Immunity on Oncolytic Adenovirus Vector INGN 007 Antitumor Efficacy in Immunocompetent and Immunosuppressed Syrian Hamsters
  di: Dhar, Debanjan, et al.
  Pubblicazione: (2009)
• The role of cyclophosphamide in enhancing antitumor efficacy of an adenovirus oncolytic vector in subcutaneous Syrian hamster tumors
  di: Young, Brittany A., et al.
  Pubblicazione: (2013)
• The effects of radiation on antitumor efficacy of an oncolytic adenovirus vector in the Syrian hamster model
  di: Young, Brittany A., et al.
  Pubblicazione: (2013)
• Immunosuppression Enhances Oncolytic Adenovirus Replication and Antitumor Efficacy in the Syrian Hamster Model
  di: Thomas, Maria A, et al.
  Pubblicazione: (2008)